A5093637430- Cardiovascular Function and Risk Factors
- Pulmonary Hypertension Research and Treatments
- Gout, Hyperuricemia, Uric Acid
- Heart Failure Treatment and Management
- Liver Disease and Transplantation
Research Medical Center
2024
National Medical Research Center of Cardiology
2024
Aim. To evaluate the effect of prior administration soluble guanylate cyclase stimulator riociguat on incidence and severity reperfusion lung injury after balloon pulmonary angioplasty (BPA) in patients with inoperable form chronic thromboembolic hypertension (CTEPH). Materials methods . 70 CTEPH were included study. Patients divided into 2 groups: Group 1 (n=41) – who had received PAH-specific therapy at time BPA, (n=29) underwent BPA without riociguat. In postoperative period all...
This review presents current data regarding the relationship between hyperuricemia, obesity, diabetes mellitus, lipid disorders and pulmonary arterial hypertension (PAH), chronic thromboembolic (CTEPH). Hyperuricemia is associated with a higher risk of developing PAH, worse prognosis PAH greater severity patient's condition. Obesity leads to development pro-inflammatory vasoconstrictor effects, hypoxia, which contributes progression PH, however, survival rate patients PH overweight or...
To analyze the relationship between metabolic disorders and obesity with hemodynamic parameters severity of condition patients chronic thromboembolic pulmonary hypertension (CTEPH) based on POLET register.